New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties

por Yu, Chungping, Garcia-Olivares, Jennie, Candler, Shawn, Schwabe, Stefan, Maletic, Vladimir
Publicado 2020

What is the speed limit of martensitic transformations?

por Schwabe, Stefan, Lünser, Klara, Schmidt, Daniel, Nielsch, Kornelius, Gaal, Peter, Fähler, Sebastian
Publicado 2022

Predicted Efficacy of Once-Daily Extended-Release Oxcarbazepine (Oxtellar XR(®)) Monotherapy in Adults and Children with Partial-Onset Seizures: Exposure-Response Modeling and Simu...

por Faison, Shamia, Gomeni, Roberto, Mendes, Shannon, O’Neal, Welton, Schwabe, Stefan, Nasser, Azmi
Publicado 2020

Reversible tuning of magnetocaloric Ni-Mn-Ga-Co films on ferroelectric PMN-PT substrates

por Schleicher, Benjamin, Niemann, Robert, Schwabe, Stefan, Hühne, Ruben, Schultz, Ludwig, Nielsch, Kornelius, Fähler, Sebastian
Publicado 2017

Impact of a High-Fat Meal and Sprinkled Administration on the Bioavailability and Pharmacokinetics of Viloxazine Extended-Release Capsules (Qelbree(TM)) in Healthy Adult Subjects

por Wang, Zhao, Kosheleff, Alisa R, Adeojo, Lilian W, Odebo, Oyinkansola, Liranso, Tesfaye, Schwabe, Stefan, Nasser, Azmi
Publicado 2021

Population Pharmacokinetics of Viloxazine Extended‐Release Capsules in Pediatric Subjects With Attention Deficit/Hyperactivity Disorder

por Nasser, Azmi, Gomeni, Roberto, Wang, Zhao, Kosheleff, Alisa R., Xie, Lanyi, Adeojo, Lilian W., Schwabe, Stefan
Publicado 2021

Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults

por Faison, Shamia L., Fry, Nicholas, Adewole, Toyin, Odebo, Oyinkansola, Schwabe, Stefan, Wang, Zhao, Maletic, Vladimir, Nasser, Azmi
Publicado 2020

Impact of Paroxetine, a Strong CYP2D6 Inhibitor, on SPN‐812 (Viloxazine Extended‐Release) Pharmacokinetics in Healthy Adults

por Wang, Zhao, Kosheleff, Alisa R., Adeojo, Lilian W., Odebo, Oyinkansola, Adewole, Toyin, Qin, Peibing, Maletic, Vladimir, Schwabe, Stefan, Nasser, Azmi
Publicado 2021

A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD

por Johnson, Janet K., Liranso, Tesfaye, Saylor, Keith, Tulloch, Gabriela, Adewole, Toyin, Schwabe, Stefan, Nasser, Azmi, Findling, Robert L., Newcorn, Jeffrey H.
Publicado 2019

Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status

por Findling, Robert L., Candler, Shawn A., Nasser, Azmi F., Schwabe, Stefan, Yu, Chungping, Garcia-Olivares, Jennie, O’Neal, Welton, Newcorn, Jeffrey H.
Publicado 2021

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperacti...

por Nasser, Azmi, Hull, Joseph T., Chaturvedi, Soumya A., Liranso, Tesfaye, Odebo, Oyinkansola, Kosheleff, Alisa R., Fry, Nicholas, Cutler, Andrew J., Rubin, Jonathan, Schwabe, Stefan, Childress, Ann
Publicado 2022

A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder

por Nasser, Azmi, Liranso, Tesfaye, Adewole, Toyin, Fry, Nicholas, Hull, Joseph T., Busse, Gregory D., Chowdhry, Fatima, Cutler, Andrew J., Jones, Nandita Joshi, Findling, Robert L., Schwabe, Stefan
Publicado 2021

A Novel Assessment Tool for Impulsive Aggression in Children with Attention-Deficit/Hyperactivity Disorder

por Ceresoli-Borroni, Gianpiera, Liranso, Tesfaye, Brittain, Scott T., Connor, Daniel F., Evans, Christopher J., Findling, Robert L., Hwang, Steve, Candler, Shawn A., Robb, Adelaide S., Nasser, Azmi, Schwabe, Stefan
Publicado 2019